Genome-wide map of p53 binding sites by ChIP-seq in human lymphoblastoid cell lines treated with doxorubicin
Ontology highlight
ABSTRACT: We have used chromatin immune-precipitation with parallel sequencing (ChIP-Seq) technology to identify genome-wide p53 binding in human lymphoblastoid cell lines treated with a DNA-damaging chemotherapeutic reagent doxorubicin.
ORGANISM(S): Homo sapiens
PROVIDER: GSE46991 | GEO | 2013/10/23
SECONDARY ACCESSION(S): PRJNA203239
REPOSITORIES: GEO
ACCESS DATA